Patterns of arginine and nitric oxide in patients with sickle cell disease with vaso-occlusive crisis and acute chest syndrome

American Journal of Pediatric Hematology/Oncology

Volumn 22, Issue 6, 2000, Pages 515-520

  Morris, Claudia R ^a   Kuypers, Frans A ^b   Larkin, Sandra ^b   Vichinsky, Elliott P ^a   Styles, Lori A ^a  

^a CHILDREN S HOSPITAL OAKLAND   (United States)

^b CHILDREN S HOSPITAL OAKLAND RESEARCH INSTITUTE   (United States)

Author keywords

Acute chest syndrome; L arginine; Nitric oxide; Sickle cell disease; Vaso occlusive crisis

Indexed keywords

ARGININE; BIOLOGICAL MARKER; NITRIC OXIDE;

ACUTE DISEASE; ADOLESCENT; ADULT; ARTICLE; BLOOD; BLOOD TRANSFUSION; CHILD; FEMALE; HUMAN; INFARCTION; MALE; PAIN; PATHOPHYSIOLOGY; PRESCHOOL CHILD; SICKLE CELL ANEMIA; SYNDROME; THORAX;

ACUTE DISEASE; ADOLESCENT; ADULT; ANEMIA, SICKLE CELL; ARGININE; BIOLOGICAL MARKERS; BLOOD TRANSFUSION; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFARCTION; MALE; NITRIC OXIDE; PAIN; SYNDROME; THORAX;

EID: 0034321784     PISSN: 01928562     EISSN: None     Source Type: Journal    
DOI: 10.1097/00043426-200011000-00009     Document Type: Article

References (38)

1. Moncada S, Higgs A. The L-Arginine-Nitric Oxide Pathway. N Engl J Med 1993; 329: 2002-2112.
2. Kam PC, Govender G. Nitric oxide: Basic science and clinical applications. Anaesthesia 1994; 49: 515-21.
3. Kiechle FL, Malinski T. Nitric oxide: Biochemistry, pathophysiology, and detection. Am J Clin Pathol 1993; 100: 567-75.
4. Guyton AC. Textbook of Medical Physiology. Philadelphia: WB Saunders Co, 1996.
5. Ignarro LJ. Heme-dependent activation of soluble guanylate cyclase by nitric oxide: Regulation of enzyme activity by porphyrins and metalloporphyrins. Semin Hematol 1989; 26: 63-76.
6. Palmer RM, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987; 327: 524-6.
7. Marin J, Rodriguez-Martinez A. Role of vascular nitric oxide in physiological and pathological conditions. Pharmacol Ther 1997; 75: 111-34.
8. Pieper GM. Review of alterations in endothelial nitric oxide production in diabetes. Protective role of arginine on endothelial dysfunction. Hypertension 1998; 31: 1047-60.
9. Woodman DL. Modulation of vasoconstriction by endothelial-derived nitric oxide: The influence of vascular disease. Clin Exp Pharmacol Physiol 1995; 22: 585-93.
10. Enwonwu CO. Increased metabolic demand for arginine in sickle cell anaemia. Med Sci Res 1989; 17: 997-8.
11. Enwonwu CO, Xu X, Turner E. Nitrogen metabolism in sickle cell anemia: Free amino acids in plasma and urine. Am J Med Sci 1990; 300: 366-71.
12. Rees DC, Cervi P, Grimwade D, et al. The metabolites of nitric oxide in sickle-cell disease. Br J Haematol 1995; 91: 834-7.
13. Lopez BL, Barnett J, Ballas SK, et al. Nitric oxide metabolite levels in acute vaso-occlusive sickle-cell crisis. Acad Emerg Med 1996; 3: 1098-1103.
14. Davidson W, Woof C. Comparison of different forms of cadmium as reducing agents for the batch determination of nitrate. Analyst 1978; 103: 403.
15. Thomsen L, Ching L, Zhuang L, et al. Tumor-dependent increased plasma nitrate concentrations as an indication of the antitumor effect of flavone-8-acetic acid and analogues in mice. Cancer Res 1991; 51: 77-81.
16. Moncada S, Palmer RM, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991; 43: 109-42.
17. Stuart M, Setty Y. Sickle cell acute chest syndrome: Pathogenesis and rationale for treatment. Blood 1999; 94: 1555-60.
18. Waugh WH, Daeschner CW, Liles BA. Low plasma arginine levels correlate with high plasma hemoglobin and serum lactate dehydrogenase levels in sickle cell anemia. National Sickle Cell Disease Conference Washington, DC 1997;A98 (abstract).
19. Francis Jr., RB, Haywood LJ. Elevated immunoreactive tumor necrosis factor and interleukin-1 in sickle cell disease. J Natl Med Assoc 1992; 84: 611-15.
20. Remick DG, Villaret L. Regulation of cytokine gene expression by reactive oxygen and reactive nitrogen intermediates. J Leukoc Biol 1996; 59: 471-5.
21. Dias-Da-Motta P, Muscara M, Saad S, et al. The release of nitric oxide and superoxide anion by neutrophils and mononuclear cells from patients with sickle cell anaemia. Br J Haematol 1996; 93: 333-40.
22. Xia Y, Dawson V, Dawson T, et al. Nitric oxide synthase generates superoxide and nitric oxide in arginine-depleted cells leading to peroxynitrite-mediated cellular injury. Proc Natl Acad Sci 1996; 93: 6770-4.
23. Mosseri M, Bartlett-Pandite A, Went K, et al. Inhibition of endothelium-dependent vasorelaxation by sickle erythrocytes. Am Heart J 1993; 126: 338-46.
24. Squadrito G, Pryor W. Oxidative chemistry of nitric oxide. The roles of superoxide, peroxynitrite and carbon dioxide. Free Radic Biol Med 1998; 25: 392-403.
25. McAndrew J, Patel R, Jo H, et al. The interplay of nitric oxide and peroxynitrite with signal transduction pathways: Implications for disease. Semin Perinatol 1997; 21: 351-66.
26. Demiryurek A, Cakici I, Kanzik I. Peroxynitrite: A putative cytotoxin. Pharmacol Toxicology 1998; 82: 113-7.
27. Koppenol W. The basic chemistry of nitrogen monoxide and peroxynitrite. Free Radic Biol Med 1998; 25: 385-91.
28. Brovkovych V, Patton S, Brovkovych S, et al. In situ measurement of nitric oxide, superoxide and peroxynitrite during endotoxemia. J Physiol Pharmacol 1997; 48: 633-44.
29. Kooy N, Royall J, Ye Y, et al. Evidence for in vivo peroxynitrite production in human acute lung injury. Am J Respir Crit Care Med 1995; 151: 1250-4.
30. Knight, J, Murphy, T, Browning I. The lung in sickle cell disease. Pediatr Pulmonol 1999; 28: 205-16.
31. Gladwin M, Schechter A, Shelhamer J, et al. The acute chest syndrome in sickle cell disease. Possible role of nitric oxide in its pathophysiology and treatment. Am J Respit Crit Care Med 1999; 159: 1368-76.
32. Atz A, Wessel D. Inhaled nitric oxide in sickle cell disease with acute chest syndrome. Anesthesiology 1997; 87: 988-90.
33. Barbul A. Arginine: Biochemistry, physiology and therapeutic implications. J Parent Enteral Nutr 1986; 10: 227-38.
34. Kline J, Hug G, Berry H, et al. Arginine deficiency syndrome. Child 1981; 135: 437-42.
35. American Society of Health Systems Pharmacists. In: McEvoy G, ed. American Hospital Formulary Service: Drug Information Bethesda, MD. 1999: 2185-6.
36. Merimee TJ, Rabinowitz D, Fineberg S. Arginine-initiated release of human growth hormone. N Engl J Med 1969; 28: 1434-8.
37. Perrine SP, Olivieri NF, Faller DV, et al. Butyrate derivatives. New agents for stimulating fetal globin production in the beta-globin disorders. Am J Pediatr Hematol Oncol 1994; 16: 67-71.
38. Kharitonov SA, Lubec G, Lubec B, et al. L-arginine increases exhaled nitric oxide in normal human subjects. Clin Sci 1995; 88: 135-9.